NEKTAR THERAPEUTICS - COM (NKTR)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
135M
Holdings value Q2 2024
$168M
Value change Q2 2024
+$31.2M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
131
Number of buys Q2 2024
6
Number of sells Q2 2024
-7
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 643K $836K -$79K $1.30 24
2024 Q2 135M $168M +$31.2M $1.24 131
2024 Q1 113M $105M -$4.64M $0.93 116
2023 Q4 119M $67.3M -$14.2M $0.57 118
2023 Q3 143M $85.1M +$3.32M $0.60 128
2023 Q2 138M $79.1M -$21.6M $0.58 139
2023 Q1 173M $121M -$6.76M $0.70 186
2022 Q4 169M $381M -$28.2M $2.26 206
2022 Q3 175M $561M -$30.2M $3.20 207
2022 Q2 182M $693M +$14.9M $3.80 205
2022 Q1 176M $947M -$12.6M $5.39 221
2021 Q4 174M $2.35B +$60.8M $13.51 231
2021 Q3 167M $3.01B -$15.3M $17.96 230
2021 Q2 168M $2.88B -$33.3M $17.16 230
2021 Q1 170M $3.39B -$52.8M $20.00 225
2020 Q4 172M $2.93B -$16.8M $17.00 230
2020 Q3 176M $2.91B -$42M $16.59 237
2020 Q2 175M $4.05B -$44.6M $23.16 249
2020 Q1 177M $3.16B +$12M $17.85 232
2019 Q4 176M $3.79B -$40.8M $21.59 270
2019 Q3 178M $3.24B +$141M $18.22 274
2019 Q2 166M $5.9B +$833M $35.58 327
2019 Q1 163M $5.47B -$66.8M $33.60 340
2018 Q4 165M $5.41B +$34.3M $32.87 322
2018 Q3 160M $9.73B -$26.5M $60.96 375
2018 Q2 160M $7.83B -$144M $48.83 368
2018 Q1 157M $16.7B +$351M $106.26 352
2017 Q4 155M $9.23B +$80.6M $59.72 264
2017 Q3 154M $3.69B +$66.2M $24.00 202
2017 Q2 151M $2.96B +$123M $19.55 196
2017 Q1 146M $3.43B +$472M $23.47 199
2016 Q4 145M $1.78B +$107M $12.27 196
2016 Q3 134M $2.29B -$7.26M $17.18 190
2016 Q2 135M $1.91B -$65.7M $14.23 174
2016 Q1 139M $1.91B -$6.78M $13.75 173
2015 Q4 139M $2.35B -$22.1M $16.85 177
2015 Q3 140M $1.54B +$33.6M $10.96 162
2015 Q2 138M $1.73B +$152M $12.51 181
2015 Q1 126M $1.39B +$59.7M $11.00 153
2014 Q4 120M $1.86B +$32.2M $15.50 163
2014 Q3 118M $1.43B +$50.2M $12.07 144
2014 Q2 114M $1.46B -$20.6M $12.82 142
2014 Q1 116M $1.4B +$165M $12.12 140